REGENTIS BIOMATERIALS LTD. - RGNT
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | History | No change | 701,685 | 1,270 | 0.41% | 0.92% | 1 | 0 | 0.0% | Q3 2026 | Nov 16, 2026 |
| Warberg Asset Management LLC | History | Reduced | 58,526 | 108 | 0.01% | 0.06% | 2 | -28,454 | -32.71% | Q3 2026 | Nov 02, 2026 |
| CITADEL ADVISORS LLC | History | New | 58,924 | 106 | 0.0% | — | 3 | +58,924 | New | Q3 2026 | Nov 16, 2026 |
| JANE STREET GROUP, LLC | History | Reduced | 43,240 | 78 | 0.0% | 0.0% | 4 | -93 | -0.21% | Q3 2026 | Nov 12, 2026 |
| Marex Group Ltd | History | New | 29,371 | 53 | 0.0% | — | 5 | +29,371 | New | Q3 2026 | Nov 16, 2026 |
| UBS Group AG | History | Added to | 1,246 | 2 | 0.0% | 0.0% | 6 | +812 | 187.1% | Q3 2026 | Nov 10, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | History | Closed out | 0 | 0 | — | 0.0% | — | -13,348 | -100.0% | Q3 2026 | Nov 12, 2026 |
| Tower Research Capital LLC (TRC) | History | Closed out | 0 | 0 | — | — | — | -11 | -100.0% | Q3 2026 | Nov 16, 2026 |